Symbols / ILMN $130.50 -1.12% Illumina, Inc.
ILMN Chart
About
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem. It also has a data partnership with Center for Data-Driven Discovery in Biomedicine to advance research in pediatric cancer and rare disease. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Fundamentals
Scroll to Statements| Market Cap | 19.95B | Enterprise Value | 20.87B | Income | 850.00M | Sales | 4.34B | Book/sh | 17.80 | Cash/sh | 10.68 |
| Dividend Yield | — | Payout | 0.00% | Employees | 8600 | IPO | — | P/E | 23.94 | Forward P/E | 22.41 |
| PEG | 2.42 | P/S | 4.59 | P/B | 7.33 | P/C | — | EV/EBITDA | 18.33 | EV/Sales | 4.81 |
| Quick Ratio | 1.58 | Current Ratio | 2.08 | Debt/Eq | 93.76 | LT Debt/Eq | — | EPS (ttm) | 5.45 | EPS next Y | 5.82 |
| EPS Growth | 86.40% | Revenue Growth | 5.00% | Earnings | 2026-04-30 | ROA | 8.39% | ROE | 33.36% | ROIC | — |
| Gross Margin | 68.25% | Oper. Margin | 19.67% | Profit Margin | 19.57% | Shs Outstand | 151.91M | Shs Float | 148.62M | Short Float | 7.46% |
| Short Ratio | 4.78 | Short Interest | — | 52W High | 155.53 | 52W Low | 73.86 | Beta | 1.49 | Avg Volume | 1.89M |
| Volume | 1.00M | Target Price | $136.11 | Recom | Buy | Prev Close | $131.98 | Price | $130.50 | Change | -1.12% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-02-09 | main | Piper Sandler | Overweight → Overweight | $170 |
| 2026-02-06 | main | JP Morgan | Neutral → Neutral | $120 |
| 2026-01-26 | main | Guggenheim | Buy → Buy | $170 |
| 2026-01-26 | main | Canaccord Genuity | Hold → Hold | $150 |
| 2026-01-20 | main | Stifel | Buy → Buy | $155 |
| 2026-01-07 | main | TD Cowen | Hold → Hold | $140 |
| 2026-01-05 | main | Guggenheim | Buy → Buy | $144 |
| 2025-12-22 | main | Canaccord Genuity | Hold → Hold | $130 |
| 2025-12-15 | main | Barclays | Underweight → Underweight | $110 |
| 2025-12-15 | main | JP Morgan | Neutral → Neutral | $130 |
| 2025-10-31 | main | Barclays | Underweight → Underweight | $100 |
| 2025-10-31 | main | Canaccord Genuity | Hold → Hold | $112 |
| 2025-10-31 | main | JP Morgan | Neutral → Neutral | $105 |
| 2025-10-31 | main | TD Cowen | Hold → Hold | $115 |
| 2025-10-31 | main | UBS | Neutral → Neutral | $120 |
| 2025-10-31 | main | Baird | Neutral → Neutral | $109 |
| 2025-10-31 | main | Evercore ISI Group | Outperform → Outperform | $142 |
| 2025-10-07 | main | Evercore ISI Group | Outperform → Outperform | $132 |
| 2025-10-02 | main | Barclays | Underweight → Underweight | $95 |
| 2025-08-04 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $105 |
- ILMN Stock Price, Quote & Chart | ILLUMINA INC (NASDAQ:ILMN) - ChartMill Mon, 20 Apr 2026 07
- DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows - PR Newswire hu, 16 Apr 2026 13
- Why Illumina (ILMN) Stock Is Up Today - Yahoo Finance Fri, 31 Oct 2025 07
- Here’s Why Illumina Stock Could Continue Its 44% Recovery Into 2026 - TIKR.com ue, 10 Mar 2026 07
- Illumina Stock Sees RS Rating Jump To 82 - Investor's Business Daily Mon, 16 Mar 2026 07
- Illumina, Inc. Stock (ILMN) Opinions on Strategic Growth and Market Expansion - Quiver Quantitative Sat, 29 Nov 2025 08
- Illumina, Inc. (ILMN) Stock Analysis: Balancing Innovation In Genomics With Market Volatility - DirectorsTalk Interviews Mon, 20 Apr 2026 09
- Illumina Stock: Competitive Threats Priced In (NASDAQ:ILMN) - Seeking Alpha Fri, 10 Apr 2026 07
- Illumina Inc. (ILMN) – Pediatric Genomics Collaboration Bolsters Long-Term Growth Narrative Amid Mixed Historical Returns - Fast Rising Picks - Xã Châu Thành Wed, 22 Apr 2026 08
- ILMN Stock Falls -9.6% In 8-day Spree On Weak 2026 Growth Outlook - Trefis hu, 12 Mar 2026 07
- Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease - PR Newswire ue, 14 Apr 2026 13
- Illumina (ILMN) Stock Trades Down, Here Is Why - Yahoo Finance Mon, 03 Nov 2025 08
- Illumina Stock: Here’s Why Numbers Suggest a 63% Upside - TIKR.com Mon, 16 Mar 2026 07
- $ILMN stock is up 18% today. Here's what we see in our data. - Quiver Quantitative Fri, 31 Oct 2025 07
- Is It Time To Reassess Illumina (ILMN) After Recent Share Price Volatility - Yahoo Finance hu, 19 Feb 2026 08
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
4,343.00
-0.66%
|
4,372.00
-2.93%
|
4,504.00
-1.75%
|
4,584.00
|
| Operating Revenue |
|
4,343.00
-0.66%
|
4,372.00
-2.93%
|
4,504.00
-1.75%
|
4,584.00
|
| Cost Of Revenue |
|
1,473.00
-2.51%
|
1,511.00
-14.15%
|
1,760.00
+9.18%
|
1,612.00
|
| Reconciled Cost Of Revenue |
|
1,473.00
-2.51%
|
1,511.00
-14.15%
|
1,760.00
+9.18%
|
1,612.00
|
| Gross Profit |
|
2,870.00
+0.31%
|
2,861.00
+4.26%
|
2,744.00
-7.67%
|
2,972.00
|
| Operating Expense |
|
2,053.00
-9.20%
|
2,261.00
-23.77%
|
2,966.00
+13.29%
|
2,618.00
|
| Research And Development |
|
967.00
-17.28%
|
1,169.00
-13.66%
|
1,354.00
+2.50%
|
1,321.00
|
| Selling General And Administration |
|
1,086.00
-0.55%
|
1,092.00
-32.26%
|
1,612.00
+24.29%
|
1,297.00
|
| Total Expenses |
|
3,526.00
-6.52%
|
3,772.00
-20.19%
|
4,726.00
+11.73%
|
4,230.00
|
| Operating Income |
|
817.00
+36.17%
|
600.00
+370.27%
|
-222.00
-162.71%
|
354.00
|
| Total Operating Income As Reported |
|
807.00
+196.88%
|
-833.00
+22.08%
|
-1,069.00
+74.42%
|
-4,179.00
|
| EBITDA |
|
1,457.00
+300.97%
|
-725.00
-19.24%
|
-608.00
+84.47%
|
-3,916.00
|
| Normalized EBITDA |
|
1,467.00
+107.20%
|
708.00
+196.23%
|
239.00
-61.26%
|
617.00
|
| Reconciled Depreciation |
|
270.00
-23.73%
|
354.00
-18.06%
|
432.00
+9.64%
|
394.00
|
| EBIT |
|
1,187.00
+210.01%
|
-1,079.00
-3.75%
|
-1,040.00
+75.87%
|
-4,310.00
|
| Total Unusual Items |
|
-10.00
+99.30%
|
-1,433.00
-69.19%
|
-847.00
+81.31%
|
-4,533.00
|
| Total Unusual Items Excluding Goodwill |
|
-10.00
+99.30%
|
-1,433.00
-69.19%
|
-847.00
+81.31%
|
-4,533.00
|
| Special Income Charges |
|
-10.00
+99.30%
|
-1,433.00
-69.19%
|
-847.00
+81.31%
|
-4,533.00
|
| Other Special Charges |
|
10.00
+102.19%
|
-456.00
-2380.00%
|
20.00
-96.77%
|
619.00
|
| Impairment Of Capital Assets |
|
0.00
-100.00%
|
1,889.00
+128.42%
|
827.00
-78.87%
|
3,914.00
|
| Restructuring And Mergern Acquisition |
|
—
|
—
|
0.00
|
0.00
|
| Net Income |
|
850.00
+169.50%
|
-1,223.00
-5.34%
|
-1,161.00
+73.64%
|
-4,404.00
|
| Pretax Income |
|
1,086.00
+192.11%
|
-1,179.00
-5.55%
|
-1,117.00
+74.24%
|
-4,336.00
|
| Net Non Operating Interest Income Expense |
|
-61.00
-12.96%
|
-54.00
-184.21%
|
-19.00
-26.67%
|
-15.00
|
| Interest Expense Non Operating |
|
101.00
+1.00%
|
100.00
+29.87%
|
77.00
+196.15%
|
26.00
|
| Net Interest Income |
|
-61.00
-12.96%
|
-54.00
-184.21%
|
-19.00
-26.67%
|
-15.00
|
| Interest Expense |
|
101.00
+1.00%
|
100.00
+29.87%
|
77.00
+196.15%
|
26.00
|
| Interest Income Non Operating |
|
40.00
-13.04%
|
46.00
-20.69%
|
58.00
+427.27%
|
11.00
|
| Interest Income |
|
40.00
-13.04%
|
46.00
-20.69%
|
58.00
+427.27%
|
11.00
|
| Other Income Expense |
|
330.00
+119.13%
|
-1,725.00
-96.92%
|
-876.00
+81.26%
|
-4,675.00
|
| Other Non Operating Income Expenses |
|
340.00
+216.44%
|
-292.00
-906.90%
|
-29.00
+79.58%
|
-142.00
|
| Gain On Sale Of Security |
|
—
|
—
|
-30.00
+76.74%
|
-129.00
|
| Gain On Sale Of Business |
|
—
|
—
|
—
|
—
|
| Tax Provision |
|
236.00
+436.36%
|
44.00
+0.00%
|
44.00
-35.29%
|
68.00
|
| Tax Rate For Calcs |
|
0.00
+3.48%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-2.17
+99.28%
|
-300.93
-69.19%
|
-177.87
+81.31%
|
-951.93
|
| Net Income Including Noncontrolling Interests |
|
850.00
+169.50%
|
-1,223.00
-5.34%
|
-1,161.00
+73.64%
|
-4,404.00
|
| Net Income From Continuing Operation Net Minority Interest |
|
850.00
+169.50%
|
-1,223.00
-5.34%
|
-1,161.00
+73.64%
|
-4,404.00
|
| Net Income From Continuing And Discontinued Operation |
|
850.00
+169.50%
|
-1,223.00
-5.34%
|
-1,161.00
+73.64%
|
-4,404.00
|
| Net Income Continuous Operations |
|
850.00
+169.50%
|
-1,223.00
-5.34%
|
-1,161.00
+73.64%
|
-4,404.00
|
| Minority Interests |
|
—
|
—
|
—
|
—
|
| Normalized Income |
|
857.83
+1043.39%
|
-90.93
+81.51%
|
-491.87
+40.23%
|
-822.93
|
| Net Income Common Stockholders |
|
850.00
+169.50%
|
-1,223.00
-5.34%
|
-1,161.00
+73.64%
|
-4,404.00
|
| Diluted EPS |
|
5.45
+170.87%
|
-7.69
-4.77%
|
-7.34
+73.79%
|
-28.00
|
| Basic EPS |
|
5.47
+171.13%
|
-7.69
-4.77%
|
-7.34
+73.79%
|
-28.00
|
| Basic Average Shares |
|
155.00
-2.52%
|
159.00
+0.63%
|
158.00
+0.64%
|
157.00
|
| Diluted Average Shares |
|
156.00
-1.89%
|
159.00
+0.63%
|
158.00
+0.64%
|
157.00
|
| Diluted NI Availto Com Stockholders |
|
850.00
+169.50%
|
-1,223.00
-5.34%
|
-1,161.00
+73.64%
|
-4,404.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
6,644.00
+5.41%
|
6,303.00
-37.66%
|
10,111.00
-17.47%
|
12,252.00
|
| Current Assets |
|
3,289.00
+19.77%
|
2,746.00
+5.25%
|
2,609.00
-26.73%
|
3,561.00
|
| Cash Cash Equivalents And Short Term Investments |
|
1,633.00
+33.85%
|
1,220.00
+15.75%
|
1,054.00
-48.26%
|
2,037.00
|
| Cash And Cash Equivalents |
|
1,418.00
+25.82%
|
1,127.00
+7.54%
|
1,048.00
-47.89%
|
2,011.00
|
| Other Short Term Investments |
|
215.00
+131.18%
|
93.00
+1450.00%
|
6.00
-76.92%
|
26.00
|
| Receivables |
|
854.00
+16.19%
|
735.00
+0.14%
|
734.00
+9.39%
|
671.00
|
| Accounts Receivable |
|
854.00
+16.19%
|
735.00
+0.14%
|
734.00
+9.39%
|
671.00
|
| Gross Accounts Receivable |
|
861.00
+15.73%
|
744.00
+0.40%
|
741.00
+9.78%
|
675.00
|
| Allowance For Doubtful Accounts Receivable |
|
-7.00
+22.22%
|
-9.00
-28.57%
|
-7.00
-75.00%
|
-4.00
|
| Inventory |
|
564.00
+3.11%
|
547.00
-6.81%
|
587.00
+3.35%
|
568.00
|
| Raw Materials |
|
254.00
+12.89%
|
225.00
-18.48%
|
276.00
+11.74%
|
247.00
|
| Work In Process |
|
398.00
-1.49%
|
404.00
+0.50%
|
402.00
+4.15%
|
386.00
|
| Finished Goods |
|
45.00
+45.16%
|
31.00
+3.33%
|
30.00
+7.14%
|
28.00
|
| Prepaid Assets |
|
—
|
—
|
—
|
—
|
| Other Current Assets |
|
238.00
-2.46%
|
244.00
+4.27%
|
234.00
-17.89%
|
285.00
|
| Total Non Current Assets |
|
3,355.00
-5.68%
|
3,557.00
-52.59%
|
7,502.00
-13.68%
|
8,691.00
|
| Net PPE |
|
1,129.00
-8.51%
|
1,234.00
-20.44%
|
1,551.00
-11.07%
|
1,744.00
|
| Gross PPE |
|
2,492.00
+0.16%
|
2,488.00
-7.47%
|
2,689.00
-0.63%
|
2,706.00
|
| Accumulated Depreciation |
|
-1,363.00
-8.69%
|
-1,254.00
-10.19%
|
-1,138.00
-18.30%
|
-962.00
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Buildings And Improvements |
|
44.00
+0.00%
|
44.00
+0.00%
|
44.00
+0.00%
|
44.00
|
| Machinery Furniture Equipment |
|
1,241.00
+2.22%
|
1,214.00
+1.00%
|
1,202.00
+7.51%
|
1,118.00
|
| Construction In Progress |
|
82.00
+110.26%
|
39.00
-59.38%
|
96.00
-27.27%
|
132.00
|
| Other Properties |
|
370.00
-11.69%
|
419.00
-22.98%
|
544.00
-16.69%
|
653.00
|
| Leases |
|
755.00
-2.20%
|
772.00
-3.86%
|
803.00
+5.80%
|
759.00
|
| Goodwill And Other Intangible Assets |
|
1,323.00
-6.04%
|
1,408.00
-74.58%
|
5,538.00
-15.11%
|
6,524.00
|
| Goodwill |
|
1,113.00
+0.00%
|
1,113.00
-56.27%
|
2,545.00
-21.43%
|
3,239.00
|
| Other Intangible Assets |
|
210.00
-28.81%
|
295.00
-90.14%
|
2,993.00
-8.89%
|
3,285.00
|
| Non Current Deferred Assets |
|
454.00
-19.93%
|
567.00
+912.50%
|
56.00
|
—
|
| Non Current Deferred Taxes Assets |
|
454.00
-19.93%
|
567.00
+912.50%
|
56.00
|
—
|
| Other Non Current Assets |
|
449.00
+29.02%
|
348.00
-2.52%
|
357.00
-15.60%
|
423.00
|
| Total Liabilities Net Minority Interest |
|
3,921.00
-0.23%
|
3,930.00
-9.99%
|
4,366.00
-22.77%
|
5,653.00
|
| Current Liabilities |
|
1,585.00
+2.46%
|
1,547.00
-1.46%
|
1,570.00
-43.38%
|
2,773.00
|
| Payables And Accrued Expenses |
|
489.00
+7.00%
|
457.00
-54.71%
|
1,009.00
-0.69%
|
1,016.00
|
| Payables |
|
347.00
+7.76%
|
322.00
-0.62%
|
324.00
-16.92%
|
390.00
|
| Accounts Payable |
|
240.00
+8.60%
|
221.00
-9.80%
|
245.00
-16.38%
|
293.00
|
| Current Accrued Expenses |
|
142.00
+5.19%
|
135.00
-80.29%
|
685.00
+9.42%
|
626.00
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
249.00
-1.19%
|
252.00
+13.00%
|
223.00
+18.62%
|
188.00
|
| Total Tax Payable |
|
107.00
+5.94%
|
101.00
+27.85%
|
79.00
-18.56%
|
97.00
|
| Current Debt And Capital Lease Obligation |
|
577.00
-0.17%
|
578.00
+572.09%
|
86.00
-93.50%
|
1,324.00
|
| Current Debt |
|
499.00
+0.00%
|
499.00
|
—
|
1,248.00
|
| Other Current Borrowings |
|
499.00
+0.00%
|
499.00
|
—
|
1,248.00
|
| Current Capital Lease Obligation |
|
78.00
-1.27%
|
79.00
-8.14%
|
86.00
+13.16%
|
76.00
|
| Current Deferred Liabilities |
|
270.00
+3.85%
|
260.00
+3.17%
|
252.00
+2.86%
|
245.00
|
| Current Deferred Revenue |
|
270.00
+3.85%
|
260.00
+3.17%
|
252.00
+2.86%
|
245.00
|
| Total Non Current Liabilities Net Minority Interest |
|
2,336.00
-1.97%
|
2,383.00
-14.77%
|
2,796.00
-2.92%
|
2,880.00
|
| Long Term Debt And Capital Lease Obligation |
|
1,976.00
-3.33%
|
2,044.00
-6.07%
|
2,176.00
-2.47%
|
2,231.00
|
| Long Term Debt |
|
1,490.00
+0.00%
|
1,490.00
+0.07%
|
1,489.00
+0.13%
|
1,487.00
|
| Long Term Capital Lease Obligation |
|
486.00
-12.27%
|
554.00
-19.36%
|
687.00
-7.66%
|
744.00
|
| Other Non Current Liabilities |
|
360.00
+6.19%
|
339.00
-45.32%
|
620.00
-4.47%
|
649.00
|
| Stockholders Equity |
|
2,723.00
+14.75%
|
2,373.00
-58.69%
|
5,745.00
-12.94%
|
6,599.00
|
| Common Stock Equity |
|
2,723.00
+14.75%
|
2,373.00
-58.69%
|
5,745.00
-12.94%
|
6,599.00
|
| Capital Stock |
|
2.00
+0.00%
|
2.00
+0.00%
|
2.00
+0.00%
|
2.00
|
| Common Stock |
|
2.00
+0.00%
|
2.00
+0.00%
|
2.00
+0.00%
|
2.00
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
201.00
+0.50%
|
200.00
+0.50%
|
199.00
+0.51%
|
198.00
|
| Ordinary Shares Number |
|
153.00
-3.77%
|
159.00
+0.00%
|
159.00
+0.63%
|
158.00
|
| Treasury Shares Number |
|
48.00
+17.07%
|
41.00
+2.50%
|
40.00
+0.00%
|
40.00
|
| Additional Paid In Capital |
|
7,822.00
+3.95%
|
7,525.00
-21.25%
|
9,555.00
+3.78%
|
9,207.00
|
| Retained Earnings |
|
-392.00
+68.44%
|
-1,242.00
-6436.84%
|
-19.00
-101.66%
|
1,142.00
|
| Gains Losses Not Affecting Retained Earnings |
|
-10.00
-145.45%
|
22.00
+2300.00%
|
-1.00
-133.33%
|
3.00
|
| Treasury Stock |
|
4,699.00
+19.45%
|
3,934.00
+3.74%
|
3,792.00
+0.99%
|
3,755.00
|
| Other Equity Adjustments |
|
-10.00
-145.45%
|
22.00
+2300.00%
|
-1.00
-133.33%
|
3.00
|
| Total Equity Gross Minority Interest |
|
2,723.00
+14.75%
|
2,373.00
-58.69%
|
5,745.00
-12.94%
|
6,599.00
|
| Total Capitalization |
|
4,213.00
+9.06%
|
3,863.00
-46.60%
|
7,234.00
-10.54%
|
8,086.00
|
| Working Capital |
|
1,704.00
+42.12%
|
1,199.00
+15.40%
|
1,039.00
+31.85%
|
788.00
|
| Invested Capital |
|
4,712.00
+8.02%
|
4,362.00
-39.70%
|
7,234.00
-22.50%
|
9,334.00
|
| Total Debt |
|
2,553.00
-2.63%
|
2,622.00
+15.92%
|
2,262.00
-36.37%
|
3,555.00
|
| Net Debt |
|
571.00
-33.76%
|
862.00
+95.46%
|
441.00
-39.09%
|
724.00
|
| Capital Lease Obligations |
|
564.00
-10.90%
|
633.00
-18.11%
|
773.00
-5.73%
|
820.00
|
| Net Tangible Assets |
|
1,400.00
+45.08%
|
965.00
+366.18%
|
207.00
+176.00%
|
75.00
|
| Tangible Book Value |
|
1,400.00
+45.08%
|
965.00
+366.18%
|
207.00
+176.00%
|
75.00
|
| Current Notes Payable |
|
—
|
—
|
—
|
500.00
|
| Inventories Adjustments Allowances |
|
-133.00
-17.70%
|
-113.00
+6.61%
|
-121.00
-30.11%
|
-93.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
1,079.00
+28.91%
|
837.00
+75.10%
|
478.00
+21.94%
|
392.00
|
| Cash Flow From Continuing Operating Activities |
|
1,079.00
+28.91%
|
837.00
+75.10%
|
478.00
+21.94%
|
392.00
|
| Net Income From Continuing Operations |
|
850.00
+169.50%
|
-1,223.00
-5.34%
|
-1,161.00
+73.64%
|
-4,404.00
|
| Depreciation Amortization Depletion |
|
270.00
-23.73%
|
354.00
-18.06%
|
432.00
+9.64%
|
394.00
|
| Depreciation |
|
203.00
-9.38%
|
224.00
-4.68%
|
235.00
+9.30%
|
215.00
|
| Amortization Cash Flow |
|
67.00
-48.46%
|
130.00
-34.01%
|
197.00
+10.06%
|
179.00
|
| Depreciation And Amortization |
|
270.00
-23.73%
|
354.00
-18.06%
|
432.00
+9.64%
|
394.00
|
| Amortization Of Intangibles |
|
67.00
-48.46%
|
130.00
-34.01%
|
197.00
+10.06%
|
179.00
|
| Other Non Cash Items |
|
19.00
+106.01%
|
-316.00
-1758.82%
|
-17.00
+91.05%
|
-190.00
|
| Stock Based Compensation |
|
275.00
-25.68%
|
370.00
-2.63%
|
380.00
+3.83%
|
366.00
|
| Asset Impairment Charge |
|
27.00
-98.60%
|
1,935.00
+108.74%
|
927.00
-76.37%
|
3,923.00
|
| Deferred Tax |
|
119.00
+206.25%
|
-112.00
-239.39%
|
-33.00
-43.48%
|
-23.00
|
| Deferred Income Tax |
|
119.00
+206.25%
|
-112.00
-239.39%
|
-33.00
-43.48%
|
-23.00
|
| Operating Gains Losses |
|
-328.00
-205.13%
|
312.00
+680.00%
|
40.00
-67.21%
|
122.00
|
| Gain Loss On Investment Securities |
|
-328.00
-205.13%
|
312.00
+680.00%
|
40.00
-67.21%
|
122.00
|
| Unrealized Gain Loss On Investment Securities |
|
—
|
—
|
22.00
+2100.00%
|
1.00
|
| Change In Working Capital |
|
-153.00
+68.32%
|
-483.00
-436.67%
|
-90.00
-144.12%
|
204.00
|
| Change In Receivables |
|
-108.00
-332.00%
|
-25.00
+37.50%
|
-40.00
-233.33%
|
-12.00
|
| Changes In Account Receivables |
|
-108.00
-332.00%
|
-25.00
+37.50%
|
-40.00
-233.33%
|
-12.00
|
| Change In Inventory |
|
-17.00
-189.47%
|
19.00
+195.00%
|
-20.00
+85.19%
|
-135.00
|
| Change In Prepaid Assets |
|
-8.00
+42.86%
|
-14.00
-227.27%
|
11.00
-31.25%
|
16.00
|
| Change In Payables And Accrued Expense |
|
2.00
+100.45%
|
-444.00
-1431.03%
|
-29.00
-108.45%
|
343.00
|
| Change In Accrued Expense |
|
0.00
+100.00%
|
-440.00
-3033.33%
|
15.00
-96.06%
|
381.00
|
| Change In Payable |
|
2.00
+150.00%
|
-4.00
+90.91%
|
-44.00
-15.79%
|
-38.00
|
| Change In Account Payable |
|
2.00
+150.00%
|
-4.00
+90.91%
|
-44.00
-15.79%
|
-38.00
|
| Change In Other Working Capital |
|
-34.00
-6.25%
|
-32.00
-100.00%
|
-16.00
-100.00%
|
-8.00
|
| Change In Other Current Assets |
|
-21.00
-40.00%
|
-15.00
-400.00%
|
5.00
-73.68%
|
19.00
|
| Change In Other Current Liabilities |
|
33.00
+17.86%
|
28.00
+2900.00%
|
-1.00
+94.74%
|
-19.00
|
| Investing Cash Flow |
|
-55.00
+69.10%
|
-178.00
+22.94%
|
-231.00
+60.91%
|
-591.00
|
| Cash Flow From Continuing Investing Activities |
|
-55.00
+69.10%
|
-178.00
+22.94%
|
-231.00
+60.91%
|
-591.00
|
| Net PPE Purchase And Sale |
|
-148.00
-15.63%
|
-128.00
+34.36%
|
-195.00
+31.82%
|
-286.00
|
| Purchase Of PPE |
|
-148.00
-15.63%
|
-128.00
+34.36%
|
-195.00
+31.82%
|
-286.00
|
| Capital Expenditure |
|
-148.00
-15.63%
|
-128.00
+34.36%
|
-195.00
+31.82%
|
-286.00
|
| Net Investment Purchase And Sale |
|
103.00
+298.08%
|
-52.00
-766.67%
|
-6.00
+85.00%
|
-40.00
|
| Purchase Of Investment |
|
—
|
-52.00
-766.67%
|
-6.00
+85.00%
|
-40.00
|
| Sale Of Investment |
|
—
|
—
|
0.00
|
0.00
|
| Net Business Purchase And Sale |
|
-10.00
-600.00%
|
2.00
+106.67%
|
-30.00
+88.68%
|
-265.00
|
| Purchase Of Business |
|
-10.00
+87.65%
|
-81.00
-170.00%
|
-30.00
+88.68%
|
-265.00
|
| Gain Loss On Sale Of Business |
|
—
|
—
|
—
|
—
|
| Net Intangibles Purchase And Sale |
|
—
|
—
|
-1.00
+99.44%
|
-180.00
|
| Purchase Of Intangibles |
|
—
|
—
|
-1.00
+99.44%
|
-180.00
|
| Financing Cash Flow |
|
-744.00
-30.53%
|
-570.00
+52.89%
|
-1,210.00
-221.00%
|
1,000.00
|
| Cash Flow From Continuing Financing Activities |
|
-744.00
-30.53%
|
-570.00
+52.89%
|
-1,210.00
-221.00%
|
1,000.00
|
| Net Issuance Payments Of Debt |
|
-5.00
-101.02%
|
491.00
+139.72%
|
-1,236.00
-224.72%
|
991.00
|
| Issuance Of Debt |
|
495.00
-60.11%
|
1,241.00
|
0.00
-100.00%
|
991.00
|
| Repayment Of Debt |
|
-500.00
+33.33%
|
-750.00
+39.32%
|
-1,236.00
|
0.00
|
| Long Term Debt Issuance |
|
495.00
-60.11%
|
1,241.00
|
0.00
-100.00%
|
991.00
|
| Long Term Debt Payments |
|
-500.00
+33.33%
|
-750.00
+39.32%
|
-1,236.00
|
0.00
|
| Net Long Term Debt Issuance |
|
-5.00
-101.02%
|
491.00
+139.72%
|
-1,236.00
-224.72%
|
991.00
|
| Net Common Stock Issuance |
|
-698.00
-1063.33%
|
-60.00
-189.55%
|
67.00
+6.35%
|
63.00
|
| Common Stock Payments |
|
-742.00
-539.66%
|
-116.00
|
0.00
|
0.00
|
| Repurchase Of Capital Stock |
|
-742.00
-539.66%
|
-116.00
|
0.00
|
0.00
|
| Net Other Financing Charges |
|
-41.00
+95.90%
|
-1,001.00
-2341.46%
|
-41.00
+24.07%
|
-54.00
|
| Changes In Cash |
|
280.00
+214.61%
|
89.00
+109.24%
|
-963.00
-220.22%
|
801.00
|
| Effect Of Exchange Rate Changes |
|
11.00
+210.00%
|
-10.00
|
0.00
+100.00%
|
-22.00
|
| Beginning Cash Position |
|
1,127.00
+7.54%
|
1,048.00
-47.89%
|
2,011.00
+63.23%
|
1,232.00
|
| End Cash Position |
|
1,418.00
+25.82%
|
1,127.00
+7.54%
|
1,048.00
-47.89%
|
2,011.00
|
| Free Cash Flow |
|
931.00
+31.31%
|
709.00
+150.53%
|
283.00
+166.98%
|
106.00
|
| Interest Paid Supplemental Data |
|
95.00
+14.46%
|
83.00
+13.70%
|
73.00
+329.41%
|
17.00
|
| Income Tax Paid Supplemental Data |
|
73.00
-30.48%
|
105.00
+61.54%
|
65.00
-46.72%
|
122.00
|
| Common Stock Issuance |
|
44.00
-21.43%
|
56.00
-16.42%
|
67.00
+6.35%
|
63.00
|
| Earnings Losses From Equity Investments |
|
—
|
—
|
0.00
|
0.00
|
| Issuance Of Capital Stock |
|
44.00
-21.43%
|
56.00
-16.42%
|
67.00
+6.35%
|
63.00
|
| Sale Of Business |
|
0.00
-100.00%
|
83.00
|
0.00
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-02 View
- 42026-04-02 View
- 8-K2026-04-02 View
- 42026-03-09 View
- 42026-03-09 View
- 42026-03-09 View
- 42026-03-09 View
- 42026-03-09 View
- 42026-03-09 View
- 42026-03-09 View
- 42026-03-09 View
- 42026-02-24 View
- 42026-02-18 View
- 42026-02-18 View
- 42026-02-18 View
- 42026-02-18 View
- 42026-02-18 View
- 42026-02-18 View
- 42026-02-18 View
- 42026-02-17 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|